Cisplatin+Capecitabine+Sintilimab
IBI308-01
Phase 2 small_molecule active
Quick answer
Cisplatin+Capecitabine+Sintilimab for Esophageal Squamous Cell Carcinoma is a Phase 2 program (small_molecule) at The First People's Hospital of Lianyungang with 1 ClinicalTrials.gov record(s).
Program details
- Company
- The First People's Hospital of Lianyungang
- Indication
- Esophageal Squamous Cell Carcinoma
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active